Get App
Amanta Healthcare IPO is a bookbuilt issue of Rs 126.00 crore. This issue is entirely a fresh issue of 1.00 crore shares with no offer for sale.
The IPO opens for subscription on September 1, 2025, and closes on September 3, 2025. The allotment is expected to be finalized on Thursday, September 4, 2025. The price band for the IPO is set at ₹120 to ₹126 per share, and the minimum lot size for an application is 119 shares.
Company Summary
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
- National sales,
- International sales and
- Product is partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Company Strengths
- Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and a diverse market.
- Large manufacturing capabilities
- Wide Domestic and International Marketing Network.
- Experienced management team supported by a large, diverse and skilled workforce.
Company Financials
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.7 |
| Profit After Tax | 10.5 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195 | 205.23 | 215.66 |
| Amount in ₹ Crore | |||
Objectives of IPO
- Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant, and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant, and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat
- General corporate purposes
Promoters of the Company
The promoters of the Company are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, and Milcent Appliances Private Limited.
IPO Details
| IPO Date | September 1, 2025, to September 3, 2025 |
| Listing Date | September 9, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹120 to ₹126 per share |
| Lot size | 119 shares |
| Total Issue size | 1,00,00,000 shares (aggregating upto ₹126.00 Cr ) |
| Issue type | Bookbuilding IPO |
| Listing at | NSE, BSE |
| Share Holding Pre Issue | 2,88,29,351 shares |
| Share Holding Post Issue | 3,88,29,351 shares |
Lot Allocation Details
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 119 | ₹14,994.00 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922.00 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916.00 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604.00 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598.00 |
Allotment Schedule
| Basis of Allotment | Thu, 4 Sep, 2025 |
| Initiation of Refunds | Mon, 8 Sep, 2025 |
| Credit of Shares to Demat | Mon, 8 Sep, 2025 |
| Tentative Listing Date | Tue, 9 Sep, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 3, 2025 |
IPO Reservation
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
To check allotment, click here
Download NOVO App!
Invest in Zero-commission Direct Mutual funds, IPO, Sovereign Gold bonds, Government bills, and Corporate bonds.
